Beijing Science Sun Pharmaceutical Co., Ltd. (SZSE:300485) agreed to acquire 5.6664% stake in Suzhou Inhal Pharma Co., Ltd. from Ningbo Menovo Ruihe Equity Investment Partnership for CNY 10 million on April 26, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.54 CNY | +0.40% | -2.08% | -28.80% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.80% | 500M | |
+37.74% | 723B | |
+32.22% | 598B | |
-2.07% | 364B | |
+20.25% | 331B | |
+2.99% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+7.43% | 169B |
- Stock Market
- Equities
- 300485 Stock
- News Beijing Science Sun Pharmaceutical Co., Ltd.
- Beijing Science Sun Pharmaceutical Co., Ltd. agreed to acquire 5.6664% stake in Suzhou Inhal Pharma Co., Ltd. from Ningbo Menovo Ruihe Equity Investment Partnership for CNY 10 million.